Brungs D, Aghmesheh M, de Souza P, Carolan M, Clingan P, Rose J, Ranson M. Elderly Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage Ill Colon Cancer. Clin Colorectal Cancer. 2018 May 31
Brungs D, Lynch D, Luk AW, Minaei E, Ranson M, Aghmesheh M, Vine KL, Carolan M, Jaber M, de Souza P, Becker TM. CTC Paper Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer. World journal of gastroenterology 24 (7), 810
Hayes AR, Brungs D, Pavlakis N. Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis. PloS one 13 (1), e0191455
Brungs D, Aghmesheh M, de Souza P, Ng W, Chua W, Carolan M, Healey E, Rose J, Tubaro T, Ranson M. Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients. BMC cancer 17 (1 ), 251, 2017
Brungs, D, Aghmesheh, M., Vine, K.L., Becker, T.M., Carolan, M.G. and Ranson, M., 2017. Expression of the urokinase plasminogen activation system in primary gastro-oesophageal cancer: A systematic review and meta-analysis. Oncotarget. 8 (14), 23099r
Brungs D, Aghmesheh M, Sjoquist K, Goldstein D. Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review. Asia Pac J Clin Oncol. 2016 Nov 10.r
Brungs, D, Aghmesheh, M., Vine, K.L., Becker, T.M., Carolan, M.G. and Ranson, M., 2015. Gastric cancer stem cells: evidence, potential markers, and clinical implications. Journal of gastroenterology, pp.1-14.
Brungs, D, Chen, J., Masson, P. and Epstein, R.J., 2014. Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis. Prostate cancer and prostatic diseases, 17(2),pp.105-111.
Brungs, D, Sze V, Emmett L, Epstein RJ. Complete Radiologic Response of Bulky Cerebral Metastases From Newly Diagnosed HER2- Positive Breast Cancer to Upfront Trastuzumab-Based Chemotherapy. World Journal of Oncology. April 2013; 4 (2)pg 122-125
Connolly K, Brungs D, Szeto E, Epstein RJ. Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma. Curr Oncol 2014; 21 (1 ): e151
Principal Research Fellow, Illawarra Health and Medical Research Institute
IHMRI research team
Dr Ann Katrin-PiperE: email@example.com | T: +61 2 4298 1958